Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr
about
Chemotherapy as an adjunct to radiotherapy in locally advanced nasopharyngeal carcinomaChemotherapy for nasopharyngeal carcinomaEmerging treatment options for nasopharyngeal carcinomaRole of chemotherapy in nasopharyngeal carcinomaWhat Is the Best Treatment of Locally Advanced Nasopharyngeal Carcinoma? An Individual Patient Data Network Meta-Analysis.Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates.Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.Current management strategy of nasopharyngeal carcinoma.Expression of cyclooxygenase (COX)-2 as a prognostic factor in nasopharyngeal cancer.Chemoradiotherapy enhanced the efficacy of radiotherapy in nasopharyngeal carcinoma patients: a network meta-analysisPropensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Efficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsRole of Chemotherapy in Stage II Nasopharyngeal Carcinoma Treated with Curative RadiotherapySurrogate End Points for Overall Survival in Loco-Regionally Advanced Nasopharyngeal Carcinoma: An Individual Patient Data Meta-analysis.Current and emerging treatment options for nasopharyngeal carcinoma.The role of induction and adjuvant chemotherapy in combination with concurrent chemoradiotherapy for nasopharyngeal cancer: a Bayesian network meta-analysis of published randomized controlled trialsThe efficiency of different chemoradiotherapy regimens in patients with paediatric nasopharynx cancer: review of 46 cases.The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.The Tumour Response to Induction Chemotherapy has Prognostic Value for Long-Term Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal Carcinoma.Prognostic Value of Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma with Low Pre-treatment Epstein-Barr Virus DNA: a Propensity-matched Analysis.Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched StudyRandomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.Nasopharyngeal carcinoma in adolescents: a retrospective review of 42 patients.Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA.Induction Chemotherapy Improved Long-term Outcomes of Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Analysis of 5-year Survival Outcomes in the Era of Intensity-modulated Radiotherapy.Role of chemotherapy in stage IIb nasopharyngeal carcinomaPrognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial.Decreased Overall and Cancer-Specific Mortality with Neoadjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma Treated by Intensity-modulated Radiotherapy: Multivariate Competing Risk Analysis.Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases.Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in nasopharyngeal carcinoma patients with cervical nodal necrosis.Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy.Clinical verification of the superiority of the current International Union Against Cancer staging criteria in an Australian population of patients with nasopharyngeal carcinoma.Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels.Comparing the efficacy of induction-concurrent with concurrent-adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a propensity score matching analysis.Prognostic value of chemotherapy in addition to concurrent chemoradiotherapy in T3-4N0-1 nasopharyngeal carcinoma: a propensity score matching study.Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study.The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.
P2860
Q24243898-588D4DCA-5C60-45B3-9767-4C14BE6DFD9FQ24250146-EA2F9BBD-A52F-4791-8C3A-C0F252AE2C62Q26995560-EF0324BA-E275-4978-8C30-734C6EFC0BB4Q27022454-F7408D52-D9F8-4299-9A25-490BFEB08B17Q31146986-E4030B4C-5BB2-4057-A543-77FDD5F5C979Q33346719-3EC64598-A8B1-4AC3-B4DA-00D7E6563FE3Q33439337-2452606C-946F-4F00-B562-D123D73F273DQ33764579-E78C5A74-F941-416F-8B18-87F48C93F061Q33791341-9D064818-988C-4802-9963-7065DCC76391Q33889391-145D3E5A-222E-4900-8F8E-EC6D2C669B2DQ35823316-DE4829EB-606E-46CF-915B-5DE0C485831AQ35942191-3402E954-7E04-419E-B0E9-4236A18CCB47Q36043428-A9017DF1-E3FA-4F08-8E5F-D32ECB779A05Q36065641-9EAB08E6-E928-4F7B-ABA2-B34352E56F20Q36187049-D6D18F42-CBD8-4538-802A-57B61A771EE6Q36215439-45E603E6-42D8-44FB-8301-FE34D35233D5Q36359374-D4E45F55-100E-4E00-93EE-ED2D772020C0Q36450771-3DFCBCB7-141C-4D99-A353-EA122FA8B0EAQ36513247-B0B21427-3B83-41C6-BB64-B6AB8A48DEC2Q36793052-63003C60-70EC-4A48-B13C-B0193607297DQ36819870-6B5BE3DC-F2AA-4DA6-AE6A-0F82D20E9CD4Q37133656-C8111C8B-77B7-4F66-9F0A-BAAAC5C1BB21Q37221893-46B5838F-76B4-49A9-A24B-C20DBDA296AEQ37353983-5AE49862-11CD-4E27-BB72-DE53D784A64FQ37374492-9A6AEFA9-57A8-48BC-A002-F1F51B9EC02EQ37520639-FCA232F6-6916-4016-82D6-667CF598DF15Q37675943-82E5D0BF-5E2C-4AD0-B2CE-D527E767D7F1Q38024880-01E14512-6A8C-446D-81E0-D690C396C76AQ40633739-6D2D8373-DC73-4E89-B1B0-FB9A8FE2928CQ41242545-02AD88E2-3B0A-4342-90F7-CAE42298924DQ41721746-BD1CAD83-1F88-43CF-89D3-178B8631C362Q41846802-4E6F6526-26B1-407B-A4B3-D752C7E2B5DDQ44472236-9AB76A59-075F-4DC8-88FC-2DBBDD657A55Q44917316-4ADF2F96-98CD-4AF9-9617-8387D1C26F10Q45354343-8300894E-A9A4-442F-850F-DA7CCCC5712CQ45814922-DD35BC61-EB1E-4143-85D0-1DC56E80DD2EQ46721131-53B163D6-D00D-4BE5-AECD-F7F2D2400C79Q46793662-C123FB51-C18F-4849-8A6F-28C05738F8B5Q47115446-89001EB1-C2BC-401A-A417-9E7865E6FC48Q47122053-39DE0428-DED3-4EC6-B647-7203BA2AE46A
P2860
Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV(> or = N2, M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progr
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Preliminary results of a rando ...... ma: a positive effect on progr
@en
Preliminary results of a rando ...... ma: a positive effect on progr
@nl
type
label
Preliminary results of a rando ...... ma: a positive effect on progr
@en
Preliminary results of a rando ...... ma: a positive effect on progr
@nl
prefLabel
Preliminary results of a rando ...... ma: a positive effect on progr
@en
Preliminary results of a rando ...... ma: a positive effect on progr
@nl
P1476
Preliminary results of a rando ...... ma: a positive effect on progr
@en
P2093
International Nasopharynx Cancer Study Group
VUMCA I Trial
P304
P356
10.1016/S0360-3016(96)80007-1
P407
P577
1996-06-01T00:00:00Z